
25 February 2020
Cytox MedNous coverage: Genetic risk assessment in Alzheimer's disease
Dr Alex Gibson, Business Development Officer at Cytox discusses in MedNous how to predict a person’s genetic risk of developing Alzheimer's using Polygenic Risk Scores. First application is identifying patients most suitable to enter clinical trials, based on risk of significant cognitive decline.